Le Lézard
Classified in: Science and technology
Subject: PLW

Appeals Court Reverses Dismissal of Patents in Oregon Proceeding


MOUNTAIN VIEW, Calif., March 16, 2017 /PRNewswire/ -- Synopsys, Inc. (Nasdaq:SNPS) today announced that a federal appellate court has affirmed an Oregon jury's finding that certain features of Synopsys' ZeBu software product infringed a Mentor Graphics patent, and affirmed the jury's damages award of $36 million. This ruling has no impact on Synopsys' sales or support of ZeBu emulation systems, as these systems no longer include the features found to infringe. Synopsys disagrees with the ruling and may seek further review.

The appellate court also reversed the trial court's dismissal of three other Mentor patents asserted against ZeBu, two of which have expired. Proceedings on those patents will resume in the trial court and could last up to two years. Synopsys believes that it does not infringe these patents and that they are invalid, and will vigorously defend the new proceedings.

The court granted Synopsys' appeal regarding its '109 patent (U.S. Patent No. 6,132,109) asserted against Mentor. Proceedings on that patent will resume in the trial court and could also last up to two years.

Synopsys sells, ships and supports ZeBu emulation systems worldwide, and is committed to investing in and expanding our emulation business. ZeBu is the fastest-growing emulation system in the industry, reflecting its unmatched performance and scalability. 

About Synopsys

Synopsys, Inc. (Nasdaq: SNPS) is the Silicon to Softwaretm partner for innovative companies developing the electronic products and software applications we rely on every day. As the world's 15th largest software company, Synopsys has a long history of being a global leader in electronic design automation (EDA) and semiconductor IP and is also growing its leadership in software security and quality solutions. Whether you're a system-on-chip (SoC) designer creating advanced semiconductors, or a software developer writing applications that require the highest security and quality, Synopsys has the solutions needed to deliver innovative, high-quality, secure products. Learn more at www.synopsys.com.

Editorial Contact:                                                          

Carole Murchison
Synopsys, Inc.
650-584-4632
[email protected]

Investor Contact:

Lisa Ewbank
Synopsys, Inc.
650-584-1901
[email protected]

 

SOURCE Synopsys, Inc.


These press releases may also interest you

at 23:16
OKX, a leading Web3 technology company, today announced the integration of Side Protocol with the OKX Wallet. Side Protocol is a cross-chain middleware protocol designed to enable seamless communication and asset transfer between heterogeneous...

at 23:05
OKX, a leading Web3 technology company, today announced the integration of Biturbo with the OKX Wallet. Bitrubo is an innovative layer 2 solution that brings the power of Ethereum's smart contracts to the Bitcoin network. Biturbo is designed as an...

at 23:03
The report titled "Cognitive Security Market by Component (Services, Solutions), Security Type (Application, Cloud, Cybersecurity), Application, Deployment Mode, Enterprise Type, Vertical - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...



News published on and distributed by: